AGIX

AtheroGenics, Inc.

NASDAQ

Add Alert

AGIX

AtheroGenics, Inc.

NASDAQ

Add Alert

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

Older

JJdivini

06/10/09 8:14 AM

Post #1,234

Re: #1,233: @MrBigz - morning JJ

Good Morning buddy!

MrBigz

06/10/09 7:56 AM

Post #1,233

Re: #1,232: @JJdivini - AtheroGenics, Inc., (AGIXQ) Plan Confirmed...

morning JJ

JJdivini

06/10/09 3:39 AM

Post #1,232

Re: #1,223: @MrBigz - AGIXQ pinching

AtheroGenics, Inc., (AGIXQ) Plan Confirmed...

June 10, 2009;

The U.S. Bankruptcy Court issued an order confirming AtheroGenics'Second Amended Plan, as modified. Pursuant to the Plan, all property of the Debtor and its estate, including cash, will vest automatically in the post-confirmation Debtor and the liquidating fund on the effective date, free and clear of all liens, claims, and interests and without the need for the execution or delivery of any instruments of assignment, for the express purpose of, among other things, allowing the liquidating agent to make distributions to holders of allowed claims pursuant to the terms and conditions of the Plan. Without limiting the foregoing, the post-confirmation Debtor will be vested with all of the Debtor's previously unsold remaining assets (including its causes of action), which will be administered, liquidated, prosecuted, settled and enforced under the direction and control of the liquidating agent. This research-based pharmaceutical company filed for Chapter 11 protection on October 15, 2008, listing total pre-petition assets of $103 million.

02/25/09 5:29 PM

Post #1,229

02/18/09 6:03 PM

Post #1,228

Why no posts for 11 days? They're still talking on Yahoo.

The Night Stalker Free

02/07/09 1:04 AM

Post #1,227

Re: #1,223: @MrBigz - AGIXQ pinching

no sir, lets do .0125 as a safe load point, volume is light

berta

02/05/09 10:29 PM

Post #1,226

Re: #1,225: @Iron Maiden - OT: Walker et al

Iron SPNG is getting interesting BUYOUT is a real possibility i believe

Iron Maiden Free

02/05/09 1:17 PM

Post #1,225

Re: #1,200: @Walker - Surprised it isn't dropping more.

OT: Walker et al

WPTE - World Poker Tour .42 x .43

Rumoured buyout of $1.50 coming....

Do you DD but may be worth a gamble IMO

Arnold25764 PremiumMember

02/05/09 2:56 AM

Post #1,224

Re: #1,222: @berta - Maybe it ain't TOAST can't sell

Doesn't make any sense if they stated shareholders aren't gettin' anything after they sell the company???? IMO

MrBigz

02/04/09 9:27 PM

Post #1,223

Re: #1,218: @Arnold25764 - Well here is your answer folks. It appears

AGIXQ pinching

berta

02/04/09 4:37 PM

Post #1,222

Re: #1,221: @mr page - I don't get it. Why is the

Maybe it ain't TOAST can't sell at a loss NOW who Knows maybe there is a buyer after all, and Holders will benefit. PEACE

mr page

02/04/09 3:17 PM

Post #1,221

I don't get it. Why is the price moving up? This is toast right? Brokers should not be trading these share.

berta

01/28/09 2:34 PM

Post #1,220

looks like we might not be done afterall a little rebound from the low doesn't seem to be a massive selloff havent given up hope yet!!

richboy1

01/23/09 6:31 AM

Post #1,219

Re: #1,218: @Arnold25764 - Well here is your answer folks. It appears

YEAP this ones done

Arnold25764 PremiumMember

01/23/09 3:02 AM

Post #1,218

Well here is your answer folks. It appears there will be nothing left for shareholders...IMO

AtheroGenics Provides Update on Bankruptcy Proceedings
No Proceeds From Liquidation Expected to Be Available for Shareholders

ATLANTA, GA--(MARKET WIRE)--Jan 22, 2009 -- AtheroGenics, Inc. (Other OTC:AGIXQ.PK - News), a pharmaceutical company focused on the treatment of chronic inflammatory diseases, today provided an update on its bankruptcy proceedings, during which it expects to sell the company and/or its key assets. The date to receive initial offers from potential purchasers of the Company's key assets has now passed and the Company and its financial advisor, Merriman Curhan Ford & Co., have concluded that the amount of the expected sale proceeds when combined with its cash on hand will be substantially less than the Company's outstanding liabilities. Therefore, the Company believes there will be no proceeds available for distribution to its shareholders. The Company cannot predict when the bankruptcy proceedings will be finalized.
Related Quotes
Symbol Price Change
AGIXQ.PK 0.0550 -0.0250
Chart for ATHEROGENICS INC #
{"s" : "agixq.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""}

Disclosure Regarding Forward-Looking Statements

Statements contained in this press release that relate to events or developments that we expect or anticipate will occur in the future are deemed to be forward-looking statements, and can be identified by words such as "believes," "intends," "expects" and similar expressions. AtheroGenics cautions investors not to place undue reliance on the forward-looking statements contained in this release. In this press release, the Company predicts that the sale of the Company and/or its key assets will not exceed the liabilities owed to the Company's creditors, which would result in no proceeds ultimately being available for distribution to shareholders. This and other such statements are subject to certain factors, risks and uncertainties that may cause actual outcomes to differ materially from those referred to in such statements. The Company cannot predict with certainty the ultimate amount that will be realized from the liquidation of its assets. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

Arnold25764 PremiumMember

01/23/09 3:00 AM

Post #1,217

Damn, This one took a tumble! IMO

berta

01/22/09 8:03 PM

Post #1,216

Re: #1,215: @berta - AOK thanks I'm holding here

Anyone care to explain why the stock had a small rally in the afternoon?????

berta

01/22/09 3:48 PM

Post #1,215

Re: #1,214: @Iron Maiden - Bert... I sold this morning at .07 after

AOK thanks I'm holding here GOOD luck

Iron Maiden Free

01/22/09 2:35 PM

Post #1,214

Re: #1,212: @berta - Iron Do you think this is

Bert... I sold this morning at .07 after seeing the PR ... I will wait and watch to see what happens...

SPNG scares me... been there done that situation too many times...hard to tell if management if blowing smoke up our arses or not. That smells like CMKX more than any other stock I've seen and even tho I did well on CMKX...the whole thing was a huge scam ... Good luck my friend, I hope it works out in your favor

I am playing NBS and MDLK right now ...

Iron Maiden Free

01/22/09 2:35 PM

Post #1,213

Re: #1,212: @berta - Iron Do you think this is

berta

01/22/09 2:25 PM

Post #1,212

Re: #1,210: @Iron Maiden - WHICH ONE???

Iron Do you think this is toast looks like there is still some hope BY THE WAY SPNG looking good

shakerzzz

01/22/09 2:20 PM

Post #1,211

Re: #1,210: @Iron Maiden - WHICH ONE???

hold on teaching lispy how to swing skf lol

Iron Maiden Free

01/22/09 2:19 PM

Post #1,210

Re: #1,209: @shakerzzz - THIS boatzzz getin ready to turn around

WHICH ONE???

shakerzzz

01/22/09 2:02 PM

Post #1,209

Re: #1,208: @Iron Maiden - Been watching that one too ...thanks ...!!!!

THIS boatzzz getin ready to turn around

Iron Maiden Free

01/22/09 9:49 AM

Post #1,208

Re: #1,207: @Walker - OT: If you like that I would get

Been watching that one too ...thanks ...!!!!

Walker

01/22/09 9:48 AM

Post #1,207

Re: #1,206: @Iron Maiden - OT: NBS Stem cell play starting .... I

OT: If you like that I would get some XYTS quick. Much cheaper and 6 mil. float all in long hands.

Iron Maiden Free

01/22/09 9:47 AM

Post #1,206

Re: #1,200: @Walker - Surprised it isn't dropping more.

OT: NBS Stem cell play starting .... I moved my AGIXQ proceeds into that one ...

.70 x .74 with a $2-$3 target short term...

Obama is going to reverse ban on stem cells

Jitz

01/22/09 9:42 AM

Post #1,205

Re: #1,203: @Walker - Actually some buying at the ask - strange

maybe some havent read the news yet?
did the company have to release this? maybe its normal to have initial low offers?
watching this very carefully now

goldwingeurope Free

01/22/09 9:41 AM

Post #1,204

Re: #1,203: @Walker - Actually some buying at the ask - strange

Yes, don't understand.

Walker

01/22/09 9:39 AM

Post #1,203

Re: #1,202: @goldwingeurope - Was just thinking the same!

Actually some buying at the ask - strange

goldwingeurope Free

01/22/09 9:38 AM

Post #1,202

Re: #1,200: @Walker - Surprised it isn't dropping more.

Was just thinking the same!

Jitz

01/22/09 9:37 AM

Post #1,201

Re: #1,199: @Iron Maiden - I'm out at .07 ...sorry guys...looks like our

i am out tooo, substantially lower did not sound good maybe there could be a bidding war, very risky now

Walker

01/22/09 9:37 AM

Post #1,200

Re: #1,199: @Iron Maiden - I'm out at .07 ...sorry guys...looks like our

Surprised it isn't dropping more.

Iron Maiden Free

01/22/09 9:31 AM

Post #1,199

Re: #1,197: @Walker - Just did - not good.

I'm out at .07 ...sorry guys...looks like our 50-50 shot just went the wrong way...

Watch for a bounce play .... :(

goldwingeurope Free

01/22/09 9:31 AM

Post #1,198

Re: #1,197: @Walker - Just did - not good.

already sold in the 1 min!

Walker

01/22/09 9:28 AM

Post #1,197

Re: #1,196: @goldwingeurope - Did you reed today' PR????

Just did - not good.

goldwingeurope Free

01/22/09 9:26 AM

Post #1,196

Re: #1,195: @Walker - Cash still basically the same.

Did you reed today' PR????

Walker

01/22/09 9:22 AM

Post #1,195

Re: #1,194: @goldwingeurope - http://ir.10kwizard.com/filing.php?doc=1&attach=ON&ipage=6081726&repo=tenk&sourc

Cash still basically the same.

goldwingeurope Free

01/22/09 8:26 AM

Post #1,194

http://ir.10kwizard.com/filing.php?doc=1&attach=ON&ipage=6081726&repo=tenk&source=1302

learning as I go Free

01/21/09 6:57 PM

Post #1,193

Re: #1,192: @Iron Maiden - hope so....

Thanks IM, I'll check it out

Iron Maiden Free

01/21/09 6:51 PM

Post #1,192

Re: #1,191: @learning as I go - down day today eh?

hope so....

OT: ... Picked up some NBS today on a stock guru friends recommendation ...

Stem cell co - very low O/S

The guy who recommended NBS I would trust with my kids and he knows what he is talking about

learning as I go Free

01/21/09 6:36 PM

Post #1,191

down day today eh?
get the rebound tomorrow

Iron Maiden Free

01/20/09 9:51 AM

Post #1,190

Bid is getting stronger ...now 2 @ .10 and 1 @ .095

cqrtdoc

01/20/09 9:21 AM

Post #1,189

Re: #1,187: @ddabetsmallwinbig - Their Phase 3 drug is what got them

Your post is inaccurate, because your information is in error...

goldwingeurope Free

01/20/09 9:12 AM

Post #1,188

Clock is ticking here, let's get some action......!!!!!

ddabetsmallwinbig PremiumMember

01/19/09 7:13 PM

Post #1,187

Re: #1,180: @NYPDBLUE - Ther eis a drug in Phase 3 that

Their Phase 3 drug is what got them in trouble. They had two drugs. The first one was a dud and their supportors dumped them which started the slide. The second drug did not meet primary endpoints but did show some promise in other areas. The results are thin at best. Unless the research has some intrinsic value this looks like a long shot. The drug pipeline thing is a hard one to follow. A strong Phase 1 and phase 2 trial (Ie: 3% - 5% ) improvement over placebo is a sure prospect but this one is bordering on the .5% area and may be passed over by the prospective buyers. Unless AGIX can provide some kind of catalyst for improving the numbers they might go home with empty pockets. Watch the news closely.IMO

ddabetsmallwinbig PremiumMember

01/18/09 2:22 PM

Post #1,186

Interesting News....

01/16/2009 00:01:00 AM
AHC Media LLC

J.P. Morgan Healthcare Conference

SAN FRANCISCO - At the 27th annual J.P. Morgan Healthcare Conference, discussions from the crowded hallways to the private meetings rooms predicted that biotech is in for a year of consolidation, but that the industry will emerge leaner and stronger.

The consolidation is well under way, as evidenced by the bankruptcies of biotechs like Introgen Therapeutics Inc., MicroIslet Inc., AtheroGenics Inc. and several others - as well as by mergers and acquisitions proposed by Cephalon Inc. with Ception Inc. The Medicines Co. with Targanta Therapeutics Corp. and Endo Pharmaceuticals Holdings Inc. with Indevus Pharmaceuticals Inc.

http://www.hoovers.com/free/co/news/detail.xhtml?ID=100118&ArticleID=200901160001AMERHC__NEWS_____b565002a1e97a679_AH&source_type%5B%5D=

Arnold25764 PremiumMember

01/17/09 12:19 AM

Post #1,185

Re: #1,184: @Walker - No FDA approval before buyout - we are

When do you think they will post news about the buyout? How much you think per PPS or possiblility to take over another companies shares?

Walker

01/16/09 11:50 PM

Post #1,184

Re: #1,181: @richboy1 - what will come first the fda approval of

No FDA approval before buyout - we are here for the buyout only.

richboy1

01/16/09 8:00 PM

Post #1,183

Re: #1,182: @berta - Richboy the company is not moving forward,

thanks

Older

AtheroGenics, Inc. (AGIX)

Followers	10	Posters	90
Posts (Today)	0	Posts (Total)	1234
Created	05/06/05	Type	Free
Moderators

WELCOME TO THE DISCUSSION BOARD FOR

ATHEROGENICS, INC.

http://www.atherogenics.com/index.html

ABOUT ATHEROGENICS, INC.

AtheroGenics is a publicly traded, emerging pharmaceutical company focused on the discovery, development and commercialization of novel pharmaceutical products that address critical unmet needs in the treatment of chronic inflammatory diseases, including diabetes and arteriosclerosis. The Company’s lead compound, AGI-1067, is a novel orally available anti-oxidant with anti-inflammatory properties that was discovered by AtheroGenics scientists. AtheroGenics is studying AGI-1067 in a Phase III clinical trial called ANDES (AGI-1067 as a Novel Anti-Diabetic Agent Evaluation Study) to assess the ability of AGI-1067 to control blood sugar levels in patients with diabetes. Patient enrollment in ANDES was completed in December 2007. A pre-planned interim analysis to evaluate the efficacy and safety of AGI-1067 after three months of dosing will be conducted in the second quarter of 2008. The Company expects to release final data on the full six months of dosing during the second half of 2008. AtheroGenics was incorporated in Georgia in 1993 and is based in Alpharetta, Georgia. The Company currently has 70 employees, with a senior management team comprised of executives from leading pharmaceutical companies and academic institutions.

COMPANY CONTACTS

MAILING ADDRESS:
AtheroGenics, Inc.
8995 Westside Parkway
Alpharetta, Georgia 30009
Main: (678) 336-2500
Fax: (678) 336-2501
investor@atherogenics.com

INVESTOR RELATIONS:
Stern Investor Relations, Inc.

Attention: Stephanie Ascher
19 West 87th St., Suite 400

New York, NY 10024

Main: (212) 362.1200

Email: stephanie@sternir.com

Website: www.sternir.com

TRANSFER AGENT:

American Stock Transfer and Trust Company
Shareholder Services Department
40 Wall Street, 46th Floor
New York, NY 10005
800-937-5449

SHARE STRUCTURE

Authorized: 100, 000, 000
Outstanding: 39,518,492
Float: 33,990,000
Shares Short: 7,477,000
% Owned by Insiders: 17.43 %
% Owned by Institutions: 22.70 %